LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
24.34
+0.56 (2.35%)
At close: Mar 9, 2026, 4:00 PM EDT
23.87
-0.47 (-1.93%)
After-hours: Mar 9, 2026, 4:14 PM EDT
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $615.78 million as of March 9, 2026.
Market Cap
615.78M
Enterprise Value
302.69M
1-Year Change
n/a
Ranking
Category
Stock Price
$24.34
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $615.78M, an increase of 104.24%. That is a compound annual growth rate of 339.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 601.61M | 6.83% |
| Dec 31, 2025 | 563.16M | 86.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 670.04M |
| Zura Bio | 667.92M |
| Vor Biopharma | 641.90M |
| Tectonic Therapeutic | 638.41M |
| Solid Biosciences | 624.84M |
| Larimar Therapeutics | 617.88M |
| MeiraGTx Holdings | 593.22M |
| Design Therapeutics | 591.85M |